Document is current
Any future updates will be listed below
-
Authors
Ozcariz, Enrique
Guardiola, Montse
Amigó, Núria
Valdés, Sergio
Oualla-Bachiri, Wasima
Rehues, Pere
Rojo-Martinez, Gemma
Ribalta, Josep
-
Funding
Funding for this research was provided by:
Fondo Europeo de Desarrollo Regional
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 23 October 2024
First Online: 7 November 2024
Declarations
:
: Written informed consent was obtained from all the participants. The study was approved by the Ethics and Clinical Investigation Committee of the Hospital Regional Universitario de Málaga (Málaga, Spain) in addition to other regional ethics and clinical investigation committees all over Spain.
: N.A. is stock owner of Biosfer Teslab and has a patent on the method for lipoprotein profiling described in the present manuscript. E.O. was employed at Biosfer Teslab. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper interests or personal relationships that could have appeared to influence the work reported in this paper.
: Not applicable.
